SCHEMBL322512

SCHEMBL322512

CCC=C(C)C(=O)OOCC

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
GLO1 Q04760 1/20 0.33
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CYP2D6 P10635 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7632074 1.00 GLO1 (0.33) GLO1ALDH1A1LMNAHSD17B10CYP2D6
SCHEMBL11646018 0.83 CYP2D6 (0.36) GLO1ALDH1A1LMNAHSD17B10CYP2D6
SCHEMBL317282 0.83 ALDH1A1 (0.42) ALDH1A1
SCHEMBL3384363 0.82 GLO1 (0.35) GLO1ALDH1A1LMNAHSD17B10
SCHEMBL20271512 0.82
SCHEMBL22436637 0.81 ALDH1A1 (0.41) ALDH1A1
SCHEMBL8026691 0.80 THRB (0.35) ALDH1A1CYP2D6CYP2C19
SCHEMBL17199696 0.80 ALDH1A1 (0.41) ALDH1A1
SCHEMBL28078002 0.80
SCHEMBL7080265 0.80 EP300 (0.36) ALDH1A1CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 391 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11591431-B2 Milling blank for the production of medical-technical molded parts PR03DURE MEDICAL GMBH (DE) 2023-02-28 US claimed
US-11510861-B2 Hair treatment process using a composition comprising at least one cationic acrylic copolymer L'OREAL (FR) 2022-11-29 US claimed
EP-3745998-A1 ANTIMICROBIAL POLYMER FOR USE IN OPHTHALMIC IMPLANTS KeraMed, Inc. (US) 2020-12-09 EP claimed
US-20200308332-A1 MILLING BLANK FOR THE PRODUCTION OF MEDICAL-TECHNICAL MOLDED PARTS Pro3dure Medical GmbH (DE) 2020-10-01 US claimed
US-20200268635-A1 HAIR TREATMENT PROCESS USING A COMPOSITION COMPRISING AT LEAST ONE CATIONIC ACRYLIC COPOLYMER L'OREAL (FR) 2020-08-27 US claimed
EP-3097138-B1 IMPREGNATION PROCESS FOR A FIBROUS SUBSTRATE, A LIQUID MONOMER SYRUP FOR THE IMPREGNATION PROCESS, ITS METHOD OF POLYMERIZATION AND STRUCTURED ARTICLE OBTAINED THEREOF ARKEMA FRANCE (FR) 2020-04-15 EP claimed
US-10623874-B2 Milling blank for the production of medical-technical molded parts Pro3dure Medical GmbH (DE) 2020-04-14 US claimed
CN-110461313-A For discharging probiotics and keeping the mucoadhesive device of its enzymatic activity BIOELEVEN CO LTD 2019-11-15 CN claimed
WO-2019152023-A1 ANTIMICROBIAL POLYMER FOR USE IN OPHTHALMIC IMPLANTS KeraMed, Inc. (US) 2019-08-08 WO claimed
WO-2018211069-A1 COSMETIC HAIR TREATMENT PROCESS USING A CATIONIC ACRYLIC COPOLYMER AND A CONDITIONING AGENT L'OREAL (FR) 2018-11-22 WO claimed
US-20020058724-A1 Contact lens of high water content and high water balance BENZ RESEARCH AND DEVELOPMENT CORPORATION 2002-05-16 US claimed
US-20020019455-A1 Contact lens of high water content and high water balance BENZ RESEARCH AND DEVELOPMENT CORPORATION 2002-02-14 US claimed
EP-1084427-A1 CONTACT LENS OF HIGH WATER CONTENT AND HIGH WATER BALANCE Benz Research and Development Corporation (US) 2001-03-21 EP claimed
WO-2001005578-A1 THERMOFORMABLE OPHTHALMIC LENS WESLEY-JESSEN CORPORATION (US) 2001-01-25 WO claimed
WO-1999057582-A1 CONTACT LENS OF HIGH WATER CONTENT AND HIGH WATER BALANCE BENZ RESEARCH AND DEVELOPMENT CORPORATION (US) 1999-11-11 WO claimed
US-5330686-A Crosslinked acrylic ester polymer, benzoxazine compound PPG INDUSTRIES, INC. (US) 1994-07-19 US claimed
WO-1994004952-A1 TEMPERATURE STABLE AND SUNLIGHT PROTECTED PHOTOCHROMIC ARTICLES PPG INDUSTRIES, INC. (US) 1994-03-03 WO claimed
EP-0523109-A4 HAIR STYLING SHAMPOOS 1993-10-27 EP claimed
EP-0523109-A1 HAIR STYLING SHAMPOOS THE PROCTER & GAMBLE COMPANY (US) 1993-01-20 EP claimed
WO-1991015185-A1 HAIR STYLING SHAMPOOS THE PROCTER & GAMBLE COMPANY (US) 1991-10-17 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200268635-A1 HAIR TREATMENT PROCESS USING A COMPOSITION COMPRISING AT LEAST ONE CATIONIC ACRYLIC COPOLYMER KRT18, ACR, NUP205 GLO1 1555/4885ALDH1A1 1101/4885LMNA 956/4885
US-11510861-B2 Hair treatment process using a composition comprising at least one cationic acrylic copolymer KRT18, ACR, NUP205 GLO1 1555/4885ALDH1A1 1101/4885LMNA 956/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.